Clariscan is a contrast agent commonly used in magnetic resonance imaging (MRI) procedures to enhance the visibility of internal body structures. It contains the active ingredient gadoterate meglumine, which is a type of gadolinium-based contrast agent.

When administered intravenously, Clariscan helps to improve the clarity and detail of MRI images, allowing healthcare providers to better visualize and diagnose various medical conditions. It works by altering the magnetic properties of tissues and blood vessels, making them appear brighter on the MRI scan.

Before undergoing an MRI with Clariscan, it is important to inform your healthcare provider about any allergies, medical conditions, or medications you are currently taking. Some individuals may be at a higher risk of experiencing adverse reactions to gadolinium-based contrast agents, such as those with kidney problems or a history of allergic reactions.

Common side effects of Clariscan may include headache, nausea, and a metallic taste in the mouth. In rare cases, more serious side effects such as allergic reactions or nephrogenic systemic fibrosis (NSF) may occur. It is important to seek immediate medical attention if you experience any unusual symptoms after receiving Clariscan.

Overall, Clariscan is a valuable tool in diagnostic imaging that can help healthcare providers make more accurate and timely diagnoses. If you have any questions or concerns about Clariscan or your upcoming MRI procedure, do not hesitate to discuss them with your healthcare provider. Your safety and well-being are our top priorities.